Exhibit 12.2
CERTIFICATION ON THE EFFECTIVENESS OF DISCLOSURE CONTROLS AND
PROCEDURES IN FORM 20-F FOR 2004
In the Form 20-F for 2004 I have certified that:
1. I have reviewed this annual report on Form 20-F of Novo Nordisk;
2. Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the circumstances
under which such statements were made, not misleading with respect to
the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows
of the company as of, and for, the periods presented in this report;
4. The company's other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal
control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f) for the company and have:
(a) Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
company, including its consolidated subsidiaries, is made known to us
by others within those entities, particularly during the period in
which this report is being prepared;
(b) Designed such internal control over financial
reporting, or caused such internal control over financial reporting to
be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally
accepted accounting principles;
NOVO NORDISK A/S Novo Alle Telephone: Internet:
2880 Bagsvaerd +45 4444 8888 www.novonordisk.com
Denmark CVR Number:
24 25 67 90
(c) Evaluated the effectiveness of the company's disclosure
controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as
of the end of the period covered by this report based on such
evaluation; and
(d) Disclosed in this report any change in the company's internal
control over financial reporting that occurred during the period
covered by the annual report that has materially affected, or is
reasonably likely to materially affect, the company's internal control
over financial reporting; and
5. The company's other certifying officer(s) and I have disclosed, based
on our most recent evaluation of internal control over financial
reporting, to the company's auditors and the audit committee of the
company's board of directors (or persons performing the equivalent
functions):
(a) All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to
record, process, summarize and report financial information; and
(b) Any fraud, whether or not material, that involves management
or other employees who have a significant role in the company's
internal control over financial reporting.
Date: 21 February 2005
/s/ Jesper Brandgaard
- -------------------------------------------------------
[Jesper Brandgaard]
[Chief Financial Officer]